This new component of the Center seeks to elucidate the role that a large set of genes comprehensively representing neurobiological systems involved in drug-related processes plays in the risk for substance use disorders (SUD). The genetic investigation of the major neurobiological systems that have been shown to work in concert in drug-related behavior and in drug response will take advantage of hypothesis-driven research while having a wide scope commensurate with the complexity of etiologic mechanisms. The systemic approach can considerably increase the prior probability of detecting true genetic associations, place these findings in the context of current and expanding neurobiological knowledge, and relate them to the extensive developmental psychological, psychopathological, biological, and environmental information available on the large sample of CEDAR subjects. CEDAR's high-risk/family design and uniquely rich longitudinal data and large sample enable application of the state-of-the-art genetic methods to qualitative (diagnostic) and quantitative definitions of the SUD liability phenotype, as well as to potential biobehavioral mediators and environmental moderators of its development. Both family-based and stratification-corrected population-based {genomic control) analytic approaches will be used, taking into account sex and ethnic variation. Functional neurochemical and fMRI studies will examine the biological substrate of the genetic associations found. As the majority of CEDAR's children will pass through the modal age of SUD risk in the ensuing five-year period, the genetic contribution to the transition from substance use to SUD as well as to the intergenerational transmission of the risk will be explored.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA005605-23
Application #
8646895
Study Section
Special Emphasis Panel (ZDA1-EXL-T)
Project Start
Project End
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
23
Fiscal Year
2014
Total Cost
$399,236
Indirect Cost
$110,641
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Shaffer, John R; Carlson, Jenna C; Stanley, Brooklyn O C et al. (2015) Effects of enamel matrix genes on dental caries are moderated by fluoride exposures. Hum Genet 134:159-67
Hasler, Brant P; Soehner, Adriane M; Clark, Duncan B (2015) Sleep and circadian contributions to adolescent alcohol use disorder. Alcohol 49:377-87
Ridenour, Ty A; Halliburton, Amanda E; Bray, Bethany C (2015) Does DSM-5 nomenclature for inhalant use disorder improve upon DSM-IV? Psychol Addict Behav 29:211-7
Hasler, Brant P; Soehner, Adriane M; Clark, Duncan B (2014) Circadian rhythms and risk for substance use disorders in adolescence. Curr Opin Psychiatry 27:460-6
Tarter, Ralph; Kirisci, Levent; Reynolds, Maureen (2014) A new approach to researching the etiology of cannabis use disorder: integrating transmissible and nontransmissible risk within a developmental framework. Subst Abus 35:336-43
Kirillova, Galina; Reynolds, Maureen; Kirisci, Levent et al. (2014) Familiality of addiction and its developmental mechanisms in girls. Drug Alcohol Depend 143:213-8
Parker, Andrew M; Stone, Eric R (2014) Identifying the Effects of Unjustified Confidence versus Overconfidence: Lessons Learned from Two Analytic Methods. J Behav Decis Mak 27:134-145
Clark, Duncan B; de Wit, Harriet; Iacono, William G (2014) ADHD, impulsivity and alcohol abuse: methods, results, and implications. Exp Clin Psychopharmacol 22:141-3
Blanco, Carlos; Rafful, Claudia; Wall, Melanie M et al. (2014) Towards a comprehensive developmental model of cannabis use disorders. Addiction 109:284-94
Zhai, Zu Wei; Kirisci, Levent; Tarter, Ralph E et al. (2014) Psychological dysregulation during adolescence mediates the association of parent-child attachment in childhood and substance use disorder in adulthood. Am J Drug Alcohol Abuse 40:67-74

Showing the most recent 10 out of 143 publications